Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31787
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPINHO, Flaviane Alves de-
dc.contributor.authorVENDRAME, Celia Maria Vieira-
dc.contributor.authorMACIEL, Bruna Leal Lima-
dc.contributor.authorSILVA, Lucilene dos Santos-
dc.contributor.authorMIYASHIRO, Samantha Ive-
dc.contributor.authorJERONIMO, Selma Maria Bezerra-
dc.contributor.authorGOTO, Hiro-
dc.date.accessioned2019-05-30T13:38:05Z-
dc.date.available2019-05-30T13:38:05Z-
dc.date.issued2019-
dc.identifier.citationAMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.100, n.4, p.808-815, 2019-
dc.identifier.issn0002-9637-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31787-
dc.description.abstractWe analyzed the association between insulin-like growth factor-I (IGF-I) and the pathogenesis of anemia during active visceral leishmaniasis (VL). Serum levels of IGF-I, IGF-binding protein 3 (IGFBP3), and cytokines were measured in samples from individuals with active VL and cured VL, asymptomatic Leishmania-infected, and noninfected individuals. Then, we extended our analysis to VL dogs to evaluate hematimetric parameters, bone marrow alterations, and cytokine and IGF-I expression. We identified a positive correlation between lower IGF-I and IGFBP3 levels in active VL patients and lower hemoglobin levels. In infected dogs, there was a positive correlation between lower IGF-I expression in the bone marrow and lower peripheral blood hematocrit and hemoglobin levels. There was no correlation between decreased IGF-I level/expression and any measured cytokine serum levels in either host. The data suggest that low IGF-I expression is associated with pathogenesis of anemia in active VL, primarily in severe cases, by mechanisms other than alterations in cytokine production.eng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/16257-2]-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado da Bahia [1780-2007]-
dc.description.sponsorshipConselho Nacional de Pesquisa [484499/2006]-
dc.description.sponsorshipSeropidemiology and Immunobiology Laboratory [LIM/38]-
dc.description.sponsorshipNational Institutes of Health [AI 030639]-
dc.language.isoeng-
dc.publisherAMER SOC TROP MED & HYGIENEeng
dc.relation.ispartofAmerican Journal of Tropical Medicine and Hygiene-
dc.rightsrestrictedAccesseng
dc.subject.othertumor-necrosis-factoreng
dc.subject.otherinterferon-gammaeng
dc.subject.otherigf-ieng
dc.subject.otherhematopoietic activityeng
dc.subject.otherbone-marroweng
dc.subject.othermouse modeleng
dc.subject.othererythropoiesiseng
dc.subject.otherexpressioneng
dc.subject.othercytokineseng
dc.titleAssociation between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasiseng
dc.typearticleeng
dc.rights.holderCopyright AMER SOC TROP MED & HYGIENEeng
dc.identifier.doi10.4269/ajtmh.17-0982-
dc.identifier.pmid30761980-
dc.subject.wosPublic, Environmental & Occupational Healtheng
dc.subject.wosTropical Medicineeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalPINHO, Flaviane Alves de:Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; Univ Fed Bahia, Dept Anat Patol & Clin, Escola Med Vet & Zootecnia, Salvador, BA, Brazil-
hcfmusp.author.externalMACIEL, Bruna Leal Lima:Univ Fed Rio Grande do Norte, Dept Nutricao, Ctr Ciencias Saude, Natal, RN, Brazil-
hcfmusp.author.externalSILVA, Lucilene dos Santos:Univ Fed Piaui, Setor Patol Anim, Ctr Ciencias Agr, Teresina, Brazil-
hcfmusp.author.externalMIYASHIRO, Samantha Ive:Univ Sao Paulo, Dept Clin Med, Fac Med Vet & Zootecnia, Sao Paulo, Brazil-
hcfmusp.author.externalJERONIMO, Selma Maria Bezerra:Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Natal, RN, Brazil; Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil; Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil-
hcfmusp.description.beginpage808-
hcfmusp.description.endpage815-
hcfmusp.description.issue4-
hcfmusp.description.volume100-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000467037100011-
hcfmusp.origem.id2-s2.0-85064239262-
hcfmusp.publisher.cityMCLEANeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceARKINS S, 1995, MOL ENDOCRINOL, V9, P350, DOI 10.1210/me.9.3.350eng
hcfmusp.relation.referenceAskenasy N, 2015, BLOOD REV, V29, P11, DOI 10.1016/j.blre.2014.09.002eng
hcfmusp.relation.referenceBraz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344eng
hcfmusp.relation.referenceChoi I, 2000, BLOOD, V95, P3742eng
hcfmusp.relation.referenceChoi JW, 2004, ANN CLIN LAB SCI, V34, P324eng
hcfmusp.relation.referenceCoterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000eng
hcfmusp.relation.referenceDaneshbod Y, 2010, ACTA CYTOL, V54, P12, DOI 10.1159/000324961eng
hcfmusp.relation.referencede Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451eng
hcfmusp.relation.referencedos Santos PL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004375eng
hcfmusp.relation.referenceElmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112eng
hcfmusp.relation.referenceFAN J, 1995, AM J PHYSIOL-REG I, V269, pR1204eng
hcfmusp.relation.referenceGoto Y, 2017, PARASITOL RES, V116, P457, DOI 10.1007/s00436-016-5313-xeng
hcfmusp.relation.referenceGrigorakaki C, 2011, BIOCHEM PHARMACOL, V82, P156, DOI 10.1016/j.bcp.2011.03.030eng
hcfmusp.relation.referenceHarvey JW, 2012, VET HEMATOLOGYeng
hcfmusp.relation.referenceHasegawa MY, 2005, VET CLIN PATH, V34, P213, DOI 10.1111/j.1939-165X.2005.tb00043.xeng
hcfmusp.relation.referenceKoury MJ, 2014, BLOOD REV, V28, P49, DOI 10.1016/j.blre.2014.01.002eng
hcfmusp.relation.referenceLafuse WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059509eng
hcfmusp.relation.referenceLemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478eng
hcfmusp.relation.referenceLivak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262eng
hcfmusp.relation.referenceLopes AC, 2006, TRATADO CLIN MED, V3eng
hcfmusp.relation.referenceMarini MA, 2017, ONCOTARGET, V8, P32398, DOI 10.18632/oncotarget.16132eng
hcfmusp.relation.referenceMessick J, 2010, SCHALMS VET HEMATOLOeng
hcfmusp.relation.referenceMiljus G, 2013, METALLOMICS, V5, P251, DOI 10.1039/c3mt20210keng
hcfmusp.relation.referenceMiniero R, 2012, J PEDIAT HEMATOL ONC, V34, P407, DOI 10.1097/MPH.0b013e318253f082eng
hcfmusp.relation.referenceCosta CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010eng
hcfmusp.relation.referenceNicolato RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082947eng
hcfmusp.relation.referenceO'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010eng
hcfmusp.relation.referencePinho FA, 2013, VET IMMUNOL IMMUNOP, V151, P163, DOI 10.1016/j.vetimm.2012.10.008eng
hcfmusp.relation.referencePinto AI, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006465eng
hcfmusp.relation.referencePreham O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02958eng
hcfmusp.relation.referenceRatajczak J, 1998, LEUKEMIA, V12, P371, DOI 10.1038/sj.leu.2400927eng
hcfmusp.relation.referenceSantos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198eng
hcfmusp.relation.referenceSaporito L, 2013, INT J INFECT DIS, V 17, pE572, DOI 10.1016/j.ijid.2012.12.024eng
hcfmusp.relation.referenceSavino W, 2005, ADV EXPT MED BIOL, V567eng
hcfmusp.relation.referenceSchubert T, 2003, LAB INVEST, V83, P1743, DOI 10.1097/01.LAB.0000101693.12149.2Ceng
hcfmusp.relation.referenceSchubert TEO, 2005, INT J MOL MED, V16, P753eng
hcfmusp.relation.referenceSuccurro E, 2011, THROMB HAEMOSTASIS, V105, P365, DOI 10.1160/TH10-06-0379eng
hcfmusp.relation.referenceCarvalho MDT, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/230129eng
hcfmusp.relation.referenceVarma N, 2010, INDIAN J HEMATOL BLO, V26, P78, DOI 10.1007/s12288-010-0027-1eng
hcfmusp.relation.referenceWelniak LA, 2004, BIOL BLOOD MARROW TR, V10, P32, DOI 10.1016/j.bbmt.2003.09.008eng
hcfmusp.relation.referenceZumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958eng
hcfmusp.relation.reference2014, REV INST MED TROP SP, V56, P1, DOI 10.1590/S0036-46652014000100001eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1476-1645-
hcfmusp.citation.scopus3-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPR
Departamento de Medicina Preventiva - FM/MPR

Artigos e Materiais de Revistas Científicas - LIM/38
LIM/38 - Laboratório de Epidemiologia e Imunobiologia


Files in This Item:
File Description SizeFormat 
art_PINHO_Association_between_InsulinLike_Growth_FactorI_Levels_and_the_2019.PDF
  Restricted Access
487.52 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.